A LUPUS TREATMENT
TARGETED
TWO-DRUG COMBO
THERAPY
Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus is an autoimmune disease that results in the immune system mistakenly attacking healthy tissue and organs. Severity ranges between patients; however, all are at risk for life-threatening illnesses, such as heart disease or infections. Those who suffer from lupus most commonly experience inflammation, rashes, and damage to skin, kidneys, and the heart.
The Problem
Scientists and other medical professionals do not know the definite cause of lupus, making it difficult to find a cure for patients. There are limited treatments for the disease, such as pain relievers and anti-malarials. Many are inefficient because they only serve as treatments for symptoms and take several months to show evident results.
The Solution
The Targeted Two-Drug Combo Therapy for Lupus is one step closer to a cure due to its innovative technology of targeting defective T cells in a more precise and efficient way. The membrane fusing ability of the liposome ensures quick and accurate drug delivery of metformin and 2-deoxy-D-glucose.